Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
MIMETAS publishes breakthrough study on human artery-on-a-chip model
MIMETAS, a leading organ-on-a-chip company, has announced the publication of a new peer-reviewed study that marks a major advance in cardiovascular disease research. The study, titled “Microfluidic artery-on-a-chip model with unidirectional gravity-driven flow for...
NecstGen and Astraveus explore benchtop CAR-T manufacturing
NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to simplify and scale CAR-T production. The collaboration will test the system’s potential to reduce cost, footprint,...
Synthetic antibodies that could transform drug development
What if you could design something that acts like an antibody, but cheaper, more stable, and made entirely with chemistry? Two LACDR researchers, Sebastian Pomplun and Matthias Barz, teamed up to do just that. By merging peptide synthesis with polymer chemistry, they...